G01N 2333/81
Protease inhibitors
G01N2333/81 (Protease inhibitors) appears on 469 US grants and 625 published applications in this corpus.
Search patents in G01N- Granted patents
- 469
- Published applications
- 625
- Assignees
- 425
- Inventors
- 1,515
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 2 | 0 |
| 1980 | 4 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 5 | 0 |
| 1984 | 4 | 0 |
| 1985 | 3 | 0 |
| 1986 | 2 | 0 |
| 1987 | 3 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 5 | 0 |
| 1993 | 5 | 0 |
| 1994 | 8 | 0 |
| 1995 | 9 | 0 |
| 1996 | 12 | 0 |
| 1997 | 30 | 0 |
| 1998 | 41 | 0 |
| 1999 | 17 | 0 |
| 2000 | 16 | 0 |
| 2001 | 16 | 4 |
| 2002 | 12 | 13 |
| 2003 | 13 | 31 |
| 2004 | 10 | 26 |
| 2005 | 7 | 11 |
| 2006 | 13 | 24 |
| 2007 | 5 | 24 |
| 2008 | 13 | 19 |
| 2009 | 5 | 27 |
| 2010 | 10 | 21 |
| 2011 | 9 | 33 |
| 2012 | 11 | 19 |
| 2013 | 10 | 24 |
| 2014 | 13 | 27 |
| 2015 | 12 | 46 |
| 2016 | 12 | 34 |
| 2017 | 9 | 25 |
| 2018 | 24 | 27 |
| 2019 | 13 | 29 |
| 2020 | 11 | 26 |
| 2021 | 16 | 21 |
| 2022 | 9 | 28 |
| 2023 | 8 | 22 |
| 2024 | 13 | 23 |
| 2025 | 9 | 26 |
| 2026 | 7 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Aptamer based system to quantify anti-thrombin III in blood26 May 2026US 12,637,679 B2University of Florida Research Foundation, Inc.
- Methods and compositions for differentiating progressive chronic kidney disease from stable chronic kidney disease19 May 2026US 12,631,655 B2IDEXX Laboratories, Inc.
- Cancer test method5 May 2026US 12,618,842 B2National Institute of Advanced Industrial Science and Technology
- Methods for determining the concentration of an analyte in the plasma fraction of a sample of whole blood17 Mar 2026US 12,578,330 B2Gentian AS
- Biosensor and related wound dressing system17 Feb 2026US 12,551,146 B2Mölnlycke Health Care AB
- Methods of treating endometriosis1 Oct 2026US 2026/0298926 A1Cedars-Sinai Medical Center
- Glycoprotein biomarkers for ovarian cancer diagnosis1 Oct 2026US 2026/0298932 A1Proseek Bio Pty Ltd.
- Use of kit for diagnosing or assisting in diagnosis of spn1 Oct 2026US 2026/0298937 A1Junmo (Beijing) Biotherapeutics Co., Ltd.
- Peptide substrates and inhibitors of cathepsin b10 Sep 2026US 2026/0265298 A1The Regents of the University of California
- Depletion of high-abundance plasma proteins using in situ growth of metal-organic frameworks (mofs) for proteomic analysis and biomarker discovery10 Sep 2026US 2026/0266814 A1
Most cited
By later US patents
- Methods for identifying nucleic acid ligands856US 5,270,163 AUniversity Research Corporation · 1993
- Nucleic acid ligands561US 5,475,096 AUniversity Research Corporation · 1995
- Polybifunctional reagent having a polymeric backbone and photoreactive moieties and bioactive groups478US 6,121,027 ASurModics, Inc. · 2000
- Systematic evolution of ligands by exponential enrichment: Solution SELEX337US 5,567,588 AUniversity Research Corporation · 1996
- Systematic evolution of ligands by exponential enrichment: chimeric selex281US 5,637,459 ANeXstar Pharmaceuticals, Inc. · 1997